Invention Grant
- Patent Title: Protracted exendin-4 compounds
- Patent Title (中): 延长的毒蜥外泌肽-4化合物
-
Application No.: US13212439Application Date: 2011-08-18
-
Publication No.: US08772232B2Publication Date: 2014-07-08
- Inventor: Jesper Lau , Thomas Kruse Hansen
- Applicant: Jesper Lau , Thomas Kruse Hansen
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Richard W. Bork
- Priority: DK200401536 20041007
- Main IPC: A61K38/26
- IPC: A61K38/26
Abstract:
Novel protracted exendin-4 compounds and therapeutic uses thereof.
Public/Granted literature
- US20110301084A1 Protracted Exendin-4 Compounds Public/Granted day:2011-12-08
Information query
IPC分类:
